Advisory Board Co (ABCO) 42.18 $ABCO
Shares of ABCO Up 37.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - 1 hr 11 mins ago
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 5 months, Advisory Board has returned 37.89% as of today's recent price of $42.18.
ABCO: 42.18 (+0.03)
The Advisory Board Company to Participate in Upcoming Conferences
PR Newswire - Mon Aug 29, 3:03PM CDT
The Advisory Board Company (NASDAQ: ABCO) announced today that it will participate in two upcoming investor conferences.
ABCO: 42.18 (+0.03)
INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 39.71 (+0.80), MASI: 59.43 (+0.29), ABCO: 42.18 (+0.03), INCR: 43.82 (+0.19)
Teladoc Sees Increased Service Adoption, Expenses Stay High
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 8:06AM CDT
Teladoc (TDOC) went public last July with an IPO, is engaged in offering consumers virtual visits with physicians through voice or video.
TDOC: 17.98 (+0.15), ABCO: 42.18 (+0.03), HWAY: 24.86 (-0.15), AHS: 35.68 (-0.55)
38.1% Return Seen to Date on SmarTrend Advisory Board Call (ABCO)
Comtex SmarTrend(R) - Thu Aug 25, 1:09PM CDT
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 5 months, Advisory Board has returned 38.08% as of today's recent price of $42.24.
ABCO: 42.18 (+0.03)
Zacks.com featured highlights: Coty, Advisory Board, Pan American Silver, Royal Gold and Cirrus Logic
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:30AM CDT
Zacks.com featured highlights: Coty, Advisory Board, Pan American Silver, Royal Gold and Cirrus Logic
ABCO: 42.18 (+0.03), COTY: 25.71 (-1.24), PAAS: 18.05 (+0.64), CRUS: 51.95 (+1.20), RGLD: 75.78 (+2.46)
5 Low Beta Stocks to Endure a Volatile Market
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:57AM CDT
The best idea is to create a portfolio of low beta stocks which are less prone to market movements.
ABCO: 42.18 (+0.03), COTY: 25.71 (-1.24), PAAS: 18.05 (+0.64), CRUS: 51.95 (+1.20), RGLD: 75.78 (+2.46)
For Healthcare Investing, Buy These 3 Medical Services Stocks
Zacks Premium Research - Zacks Investment Research - Wed Aug 17, 4:18PM CDT
The medical services space is gaining steam, so buy these top picks within the industry.
ABCO: 42.18 (+0.03), HWAY: 24.86 (-0.15), AHS: 35.68 (-0.55)
Why Civitas Solutions (CIVI) Could Be Positioned for a Slump
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 9:18AM CDT
Civitas Solutions (CIVI), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
ABCO: 42.18 (+0.03), CIVI: 17.94 (-0.24)
Strength Seen in Healthways Inc (HWAY): Stock Goes Up 7%
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:30AM CDT
Healthways Inc. (HWAY) shares rose over 7% in the last trading session.
ABCO: 42.18 (+0.03), HWAY: 24.86 (-0.15)
Advisory Board Shares Up 34.2% Since SmarTrend's Buy Recommendation (ABCO)
Comtex SmarTrend(R) - Wed Aug 10, 1:13PM CDT
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 5 months, Advisory Board has returned 34.19% as of today's recent price of $41.05.
ABCO: 42.18 (+0.03)
PAREXEL International (PRXL) Q4 Earnings Beat, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:12AM CDT
PAREXEL International (PRXL) reported fourth-quarter fiscal 2016 adjusted earnings per share of 94 cents.
PRXL: 68.34 (+0.31), ABCO: 42.18 (+0.03), HQY: 32.50 (-0.06), PRAH: 50.56 (+0.01)
Teladoc (TDOC) Q2 Loss Narrower Than Expected, Gives View
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 10:04AM CDT
Teladoc (TDOC) incurred loss in the quarter due to an increase in cost of advertising in its direct-to-consumer segment.
TDOC: 17.98 (+0.15), ABCO: 42.18 (+0.03), CDNA: 4.52 (-0.14), AHS: 35.68 (-0.55)
Intralign Appoints Sriram Iyer as CEO
PR Newswire - Thu Aug 04, 7:30AM CDT
Intralign Health, a leading provider of OR Optimization solutions, today announced the appointment of Sriram Iyer to the position of CEO to advance its strategy to improve hospital profitability through value-based solutions. Mr. Iyer was previously President and CEO of RainTree Oncology, a leading oncology alliance, and CEO of Engage Health, a patient engagement company focused on driving compliance.
ABCO: 42.18 (+0.03)
Community Health (CYH) Lags Q2 Earnings, Stock Plunges
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 1:56PM CDT
Community Health (CYH) reported adjusted earnings of 9 cents per share in the second quarter of 2016, which missed the Zacks Consensus Estimate of 58 cents.
ABCO: 42.18 (+0.03), CYH: 10.15 (-0.53), AHS: 35.68 (-0.55), WOOF: 70.84 (+0.03)
Cerner (CERN) Beats Q2 Earnings, Revises '16 Revenue View
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 1:49PM CDT
Cerner Corp (CERN) reported adjusted earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a penny.
ABCO: 42.18 (+0.03), STRM: 1.49 (+0.04), AHS: 35.68 (-0.55), CERN: 65.01 (+0.47)
Uptrend Call Working As Advisory Board Stock Rises 35.0% (ABCO)
Comtex SmarTrend(R) - Wed Aug 03, 12:40AM CDT
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 4 months, Advisory Board has returned 35.04% as of today's recent price of $41.31.
ABCO: 42.18 (+0.03)
Will Advisory Board (ABCO) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:34AM CDT
As of late, it has definitely been a great time to be an investor in Advisory Board Company (ABCO).
ABCO: 42.18 (+0.03)
Upgrade Alert for Advisory Board (ABCO)
Comtex SmarTrend(R) - Fri Jul 29, 3:31AM CDT
Advisory Board (NASDAQ:ABCO) was upgraded from Hold to Buy at Craig-Hallum today. The stock closed yesterday at $41.46 on volume of 1.8 million shares, above average daily volume of 473,000. The Advisory Board Company provides best practice research and analysis to the health care industry. The Company focuses on business strategy, operations, and general management issues. Advisory provides its services through discrete annual programs to a membership of hospitals, health systems, pharmaceutical and biotechnology companies, health care insurers, and medical device companies.
ABCO: 42.18 (+0.03)
The Advisory Board Company Reports Results For Quarter Ended June 30, 2016
PR Newswire - Wed Jul 27, 3:15PM CDT
The Advisory Board Company (NASDAQ: ABCO), a leading provider of insight-driven technology, research, and services for organizations in transforming industries, today announced financial results for the quarter ended June 30, 2016.
ABCO: 42.18 (+0.03)
Shares of ABCO Up 37.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - 1 hr 11 mins ago
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 5 months, Advisory Board has returned 37.89% as of today's recent price of $42.18.
ABCO: 42.18 (+0.03)
The Advisory Board Company to Participate in Upcoming Conferences
PR Newswire - Mon Aug 29, 3:03PM CDT
The Advisory Board Company (NASDAQ: ABCO) announced today that it will participate in two upcoming investor conferences.
ABCO: 42.18 (+0.03)
INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 39.71 (+0.80), MASI: 59.43 (+0.29), ABCO: 42.18 (+0.03), INCR: 43.82 (+0.19)
Teladoc Sees Increased Service Adoption, Expenses Stay High
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 8:06AM CDT
Teladoc (TDOC) went public last July with an IPO, is engaged in offering consumers virtual visits with physicians through voice or video.
TDOC: 17.98 (+0.15), ABCO: 42.18 (+0.03), HWAY: 24.86 (-0.15), AHS: 35.68 (-0.55)
38.1% Return Seen to Date on SmarTrend Advisory Board Call (ABCO)
Comtex SmarTrend(R) - Thu Aug 25, 1:09PM CDT
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 5 months, Advisory Board has returned 38.08% as of today's recent price of $42.24.
ABCO: 42.18 (+0.03)
Zacks.com featured highlights: Coty, Advisory Board, Pan American Silver, Royal Gold and Cirrus Logic
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:30AM CDT
Zacks.com featured highlights: Coty, Advisory Board, Pan American Silver, Royal Gold and Cirrus Logic
ABCO: 42.18 (+0.03), COTY: 25.71 (-1.24), PAAS: 18.05 (+0.64), CRUS: 51.95 (+1.20), RGLD: 75.78 (+2.46)
5 Low Beta Stocks to Endure a Volatile Market
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:57AM CDT
The best idea is to create a portfolio of low beta stocks which are less prone to market movements.
ABCO: 42.18 (+0.03), COTY: 25.71 (-1.24), PAAS: 18.05 (+0.64), CRUS: 51.95 (+1.20), RGLD: 75.78 (+2.46)
For Healthcare Investing, Buy These 3 Medical Services Stocks
Zacks Premium Research - Zacks Investment Research - Wed Aug 17, 4:18PM CDT
The medical services space is gaining steam, so buy these top picks within the industry.
ABCO: 42.18 (+0.03), HWAY: 24.86 (-0.15), AHS: 35.68 (-0.55)
Why Civitas Solutions (CIVI) Could Be Positioned for a Slump
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 9:18AM CDT
Civitas Solutions (CIVI), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
ABCO: 42.18 (+0.03), CIVI: 17.94 (-0.24)
Strength Seen in Healthways Inc (HWAY): Stock Goes Up 7%
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:30AM CDT
Healthways Inc. (HWAY) shares rose over 7% in the last trading session.
ABCO: 42.18 (+0.03), HWAY: 24.86 (-0.15)
Advisory Board Shares Up 34.2% Since SmarTrend's Buy Recommendation (ABCO)
Comtex SmarTrend(R) - Wed Aug 10, 1:13PM CDT
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 5 months, Advisory Board has returned 34.19% as of today's recent price of $41.05.
ABCO: 42.18 (+0.03)
PAREXEL International (PRXL) Q4 Earnings Beat, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:12AM CDT
PAREXEL International (PRXL) reported fourth-quarter fiscal 2016 adjusted earnings per share of 94 cents.
PRXL: 68.34 (+0.31), ABCO: 42.18 (+0.03), HQY: 32.50 (-0.06), PRAH: 50.56 (+0.01)
Teladoc (TDOC) Q2 Loss Narrower Than Expected, Gives View
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 10:04AM CDT
Teladoc (TDOC) incurred loss in the quarter due to an increase in cost of advertising in its direct-to-consumer segment.
TDOC: 17.98 (+0.15), ABCO: 42.18 (+0.03), CDNA: 4.52 (-0.14), AHS: 35.68 (-0.55)
Intralign Appoints Sriram Iyer as CEO
PR Newswire - Thu Aug 04, 7:30AM CDT
Intralign Health, a leading provider of OR Optimization solutions, today announced the appointment of Sriram Iyer to the position of CEO to advance its strategy to improve hospital profitability through value-based solutions. Mr. Iyer was previously President and CEO of RainTree Oncology, a leading oncology alliance, and CEO of Engage Health, a patient engagement company focused on driving compliance.
ABCO: 42.18 (+0.03)
Community Health (CYH) Lags Q2 Earnings, Stock Plunges
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 1:56PM CDT
Community Health (CYH) reported adjusted earnings of 9 cents per share in the second quarter of 2016, which missed the Zacks Consensus Estimate of 58 cents.
ABCO: 42.18 (+0.03), CYH: 10.15 (-0.53), AHS: 35.68 (-0.55), WOOF: 70.84 (+0.03)
Cerner (CERN) Beats Q2 Earnings, Revises '16 Revenue View
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 1:49PM CDT
Cerner Corp (CERN) reported adjusted earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a penny.
ABCO: 42.18 (+0.03), STRM: 1.49 (+0.04), AHS: 35.68 (-0.55), CERN: 65.01 (+0.47)
Uptrend Call Working As Advisory Board Stock Rises 35.0% (ABCO)
Comtex SmarTrend(R) - Wed Aug 03, 12:40AM CDT
SmarTrend identified an Uptrend for Advisory Board (NASDAQ:ABCO) on March 21st, 2016 at $30.59. In approximately 4 months, Advisory Board has returned 35.04% as of today's recent price of $41.31.
ABCO: 42.18 (+0.03)
Will Advisory Board (ABCO) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:34AM CDT
As of late, it has definitely been a great time to be an investor in Advisory Board Company (ABCO).
ABCO: 42.18 (+0.03)
Upgrade Alert for Advisory Board (ABCO)
Comtex SmarTrend(R) - Fri Jul 29, 3:31AM CDT
Advisory Board (NASDAQ:ABCO) was upgraded from Hold to Buy at Craig-Hallum today. The stock closed yesterday at $41.46 on volume of 1.8 million shares, above average daily volume of 473,000. The Advisory Board Company provides best practice research and analysis to the health care industry. The Company focuses on business strategy, operations, and general management issues. Advisory provides its services through discrete annual programs to a membership of hospitals, health systems, pharmaceutical and biotechnology companies, health care insurers, and medical device companies.
ABCO: 42.18 (+0.03)
The Advisory Board Company Reports Results For Quarter Ended June 30, 2016
PR Newswire - Wed Jul 27, 3:15PM CDT
The Advisory Board Company (NASDAQ: ABCO), a leading provider of insight-driven technology, research, and services for organizations in transforming industries, today announced financial results for the quarter ended June 30, 2016.
ABCO: 42.18 (+0.03)
